Health Trials

Locally Advanced or Metastatic Renal Cell Carcinoma

1

Review clinical trials related to Locally Advanced or Metastatic Renal Cell Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

To investigate the objective response rate (ORR) of stereotactic body radiotherapy (SBRT) combined with anlotinib and beromuzumab in locally advanced/metastatic renal cell carcinoma.

Participants needed: 27
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Fujian Cancer HospitalUpdated: Mar 24, 2026Locations: 1
Eligibility criteria

Aged 18 to 80 years, regardless of sex. [+7]

With contraindications to targeted or immunotherapeutic drugs. [+7]

Read more